Abstract
Over 30,000 umbilical cord blood transplants have been performed since the first umbilical cord blood transplant in France in 1988. Outcomes have improved with a better understanding of the importance of cell dose and human leukocyte antigen (HLA) matching. The selection of the appropriate umbilical cord blood unit is more challenging than choosing bone marrow or peripheral blood stem cell donors. In this section, we review the data on cell dose and HLA typing, including high resolution typing, killer immunoglobulin receptor (KIR) matching, HLA C matching, and HLA antibodies. We also analyze the importance of cord blood banking factors, ABO match, and racial/ethnic matching. Finally, we discuss the challenges of the future in cord blood selection.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical-cord blood from an HLA-identical sibling. N Eng J Med. 1989;321(17):1174–8.
Barker JN, Byam C, Scaradavou A, et al. Availability of cord blood extends allogeneic hematopoietic transplant access. Biol Blood Marrow Transplant. 2010;11:154–8.
Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344(24):1815–22.
Gluckman E, Ruggeri A, Volt F, Rocha V, et al. Milestones in umbilical cord blood transplantation. Br J Hematol. 2011;154(4):441–7.
Barker JN, Scaradavou A, Stevens C, et al. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2010;115(9):1843–9.
Barker JN, Byam C, Scaradavou A, et al. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood. 2011;117(8):2332–9.
Gluckman E, Rocha V. Improving outcomes of cord blood transplantation: HLA matching, cell dose, and other graft-and transplantation-related factors. Brit J Hematol. 2009;147:262–74.
Avery S, Shi W, Lubin M, et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood. 2011;117(12):3277–85.
Eapen M, Klein JP, Ruggeri A, et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood. 2014;123(1):133–40. C or DRB1
Eapen M, Klein JP, Sanz GF, et al. Effect of donor-recipient matching at HLA A, B, C and DRB1 on outcomes after umbilical cord blood transplantation for leukemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol. 2011;12(13):1214–21.
Garfall A, Kim H, Cutler C, et al. Allele level matching at HLA-is associated with improved survival after reduced intensity cord blood transplantation. Blood. 2012;120(21):2010a (abstract).
Cunha R, Loiseau P, Ruggeri A, et al. Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Euro-EBMT analysis. Bone Marrow Transplant. 2014;49(1):24–9.
Matsuno N, Wake A, Uchida N, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood. 2009;114:1689–95.
Cutler C, Kim HT, Sun L, et al. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood. 2011;118(25):6691–7.
Ruggeri A, Rocha V, Masson E, et al. Impact of donor specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation. Hematologica. 2013;98(7):1154–60.
Takanashi M, Atsuta Y, Fujiwara K, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood. 2010;116(15):2839–46.
Rocha V, Spellman S, Zhang MJ, et al. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant. 2012;18(12):1890–6.
van Rood JJ, Smits J, et al. Reexposure of cord blood to noninterited maternal HLA antigens improves transplant outcomes in hematological malignancies. Proc Natl Acad Sci U S A. 2009;106(47):19952–7.
Willemze R, Rodrigues CA, Labopin M, et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia. 2009;23(3):492–500.
Brunstein CG, Wagner JE, Weisdorf D, et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplants depends on transplantation conditioning intensity. Blood. 2009;113(22):5628–34.
Tanaka J, Morishima Y, Takahashi Y, et al. Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in remission. Blood Cancer J. 2013;3:e164.
Garfall A, Kim HT, Sun L, et al. KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation. Bone Marrow Transplant. 2013;48(7):1000–2.
Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397–407.
Delaney M, Ballen KK. The role of HLA in umbilical cord blood transplantation. Best Pract Res Clin Hematol. 2010;23:179–87.
Rubinstein P, Dobrila L, Rosenfield R, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A. 1995;92:10119–22.
Petz L, Jaing TH, Rosenthal J, et al. Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma-depleted or-reduced cord blood. Transfusion. 2012;52:1311–20.
Nikiforow S, Li S, Coughlin E, et al. Impact of cord blood processing conditions on outcomes after double cord blood transplantation. Blood. 2013;695a (abstract).
Guttridge MG, Soh TG, Belfield H, et al. Storage time affects umbilical cord blood viability. Transfusion. 2014;54:1278–85.
Page KM, Mendizibal A, Betz-Shablein R, et al. Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. Transfusion. 2013;54(2):340–52.
Page KM, Zhang L, Mendizibal A, et al. Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated cord blood transplantation: a single center analysis of 435 cord blood transplants. Biol Blood Marrow Transplant. 2011;17:1362–74.
Romee R, Weisdorf DJ, Brunstein C, et al. Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation. Bone Marrow Transplant. 2013;48(8):1046–9.
Ballen KK, Klein JP, Pedersen TL, et al. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2012;18(6):903–12.
Ustun C, Bachonova V, Shanley R, et al. Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2014;55(2):358–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ballen, K. (2014). Selection of the Optimal Cord Blood Unit. In: Ballen, K. (eds) Umbilical Cord Blood Banking and Transplantation. Stem Cell Biology and Regenerative Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-06444-4_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-06444-4_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06443-7
Online ISBN: 978-3-319-06444-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)